Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Side Effects to be Discovered more Quickly, Leading to Safer Prescribing

Published: Monday, April 15, 2013
Last Updated: Monday, April 15, 2013
Bookmark and Share
BMJ Learning has teamed up with the MHRA to launch a new, interactive and multimedia learning module on pharmacovigilance.

The module will support healthcare professionals know how and when to report side effects of medications – an essential element of patient safety.

Drug side effects are a major public health concern worldwide and are amongst the leading cause of death in many countries. Although no medicine is ever completely free of risk, the World Health Organization estimates that at least 60% of adverse drug reactions are preventable.

Effective reporting of drug reactions is an important way for healthcare professionals to contribute to the safer use of medicines. In the UK, this is done by completing a Yellow Card and submitting it to the MHRA. This is a quick and easy process, and can be done online or by post.

Although this Yellow Card scheme provides valuable information, its effectiveness is limited by under-reporting. Busy healthcare workers may mistakenly assume that reporting is a time consuming and complicated process, or that the information they have is not useful.

This module will help to change that view. After completing the module, healthcare professionals will understand the importance of continuous monitoring for adverse drug effects, know which type of situation should trigger a report through the Yellow Card scheme, and be able to fill out a Yellow Card correctly.

They should also know where to find up-to-date information on adverse effects of drugs, and be able to use that information to make safe prescribing choices.

One doctor who completed the module said: "Interesting and very relevant. Will encourage me to adverse report more often.” Another commented: “Very simple to follow. Good videos. Useful - will pay more attention to yellow cards from now on."

Dr June Raine, Director of Vigilance and Risk Management of Medicines at the MHRA said: "The education module that has been developed has been written for healthcare professionals who routinely make decisions about prescribing, supplying or administering medicines. We hope it provides a useful tool in professional development and increasing understanding of the role of healthcare professionals in contributing to the knowledge and understanding of the risks and side-effects of medicines. This in turn should help in making treatment choices with patients."

Dr Kieran Walsh, Clinical Director of BMJ Learning, said: "Adverse side effects to new or old drugs happen all the time, but they are not reported as often as they should be to the correct authorities. This module explains to all healthcare professionals how to do this. It is an important guide to help everyone improve their performance in this essential component of patient safety."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

MHRA Appoints New Chief Executive
The Medicines and Healthcare Products Regulatory Agency (MHRA) announced the appointment of Dr Ian Hudson as its Chief Executive.
Friday, July 05, 2013
MHRA Prioritises Science and Research Support as Part of New Corporate Plan
MHRA announced its aim to be a leading regulator on the world stage in supporting science and research as part of its new five-year corporate plan.
Monday, April 15, 2013
The Medicines Act Hits 40
The 25th October 2008 will mark the 40th birthday of the Medicines Act. For the past 40 years, the Act has served as the corner-stone of domestic medicines regulation, safe guarding public health.
Friday, October 24, 2008
New Web Resource About Medicines
From today, people can access a new authoritative source of information on the Internet about medicines.
Friday, September 26, 2008
British Pharmacopoeia Launches New Website
The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched the new British Pharmacopoeia (BP) website www.pharmacopoeia.gov.uk.
Tuesday, September 09, 2008
Scientific News
Retractable Protein Nanoneedles
The ability to control the transfer of molecules through cellular membranes is an important function in synthetic biology; a new study from researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) introduces a novel mechanical method for controlling release of molecules inside cells.
Iron in the Blood Could Cause Cell Damage
Concentrations of iron similar to those delivered through standard treatments can trigger DNA damage within 10 minutes, when given to cells in the laboratory.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Honey’s Potential to Save Lives
The healing powers of honey have been known for thousands of years.
Muscles on-a-Chip
This study may help explain why stem cell-based therapies have so far shown limited benefits for heart attack patients in clinical trials.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!